The most recent Danish nationwide cohort study involving 1,12 million women at-risk for first cancer diagnosis demonstrated that high-levels of DBP exposure were associated with a two-fold increase in the risk of developing estrogen receptor-positive breast cancer (hazard ratio, 1.9; 95% CI 1.1–3.5) [65]. This evidence concerns the gene ESR1 and cancer.